Sarah Ferguson, the former Duchess of York, has reportedly devised a controversial plan to clone a champion polo pony and sell the foals for £750,000 each. According to her cousin, Ferguson discussed this project with friends, family, and supporters over several months from 2024 to 2025. The scheme comes as Ferguson faces mounting financial difficulties, exacerbated by her association with the late billionaire financier Jeffrey Epstein.

The £750,000 Price Tag

The proposed price of £750,000 per cloned polo pony foal is a significant figure, reflecting the high value placed on champion thoroughbreds in the polo world. According to the report, Ferguson's plan involves using cloned DNA from a champion thoroughbred to create a new line of high-value polo ponies. This ambitious project aims to leverage the lucrative market for elite polo ponies, which are highly sought after by wealthy players and enthusiasts.

Financial Struggles and Epstein's Influence

Ferguson's financial woes have been well-documented, with reports indicating that she has long relied on cash handouts from Jeffrey Epstein.. as her association with the disgraced financier became increasingly tainted, Ferguson found herself without the means to support her extravagant lifestyle. according to her cousin, the cloning project was seen as a potential lifeline, offering a way out of her financial crisis.

Controversy and Ethical Concerns

The plan to clone polo ponies raises significant ethical and practical concerns. Cloning animals, particularly for commercial purposes, is a contentious issue that has sparked debate among scientists, animal welfare advocates, and the general public. Critics argue that cloning can lead to health issues for the animals and raises questions about the treatment of cloned creatures. Additionally, the high price tag of £750,000 per foal could further exacerbate concerns about the commodification of animals.

Unanswered Questions

Several key questions remain unanswered regarding Ferguson's cloning project. who will be the buyers for these high-priced foals? How will the cloning process be managed to ensure the health and welfare of the animals? And what are the long-term implications of such a venture for the polo community and the broader equine industry? According to the report, these questions have yet to be fully addressed, leaving many uncertainties surrounding the project.